Cucurbitacin B (Cucurbitane Triterpene · JAK-STAT3 Inhibitor · Colocynth · Indrayan)

Compound	Cucurbitacin B (representative; cucurbitacin class)
Chemical class	Terpenoid — Triterpene (Cucurbitane-type tetracyclic; tetracyclic triterpenoid ketol)
CAS	976-71-6 (Cucurbitacin B)
Primary source	Citrullus colocynthis (colocynth / bitter apple, fruit), Cucumis spp., Ecballium spp.
Key applications	JAK-STAT3 inhibitor (anticancer); anti-inflammatory; cytotoxic purgative (traditional); product-live via Indrayan extract
Claim strength	Moderate (anticancer preclinical); High (purgative, traditional)
Typical form	Colocynth/Indrayan extract (cucurbitacins as primary actives); cucurbitacin B isolate (research grade)
Buy from Herbuno	Indrayan Oil Soluble Extract - Citrullus colocynthis →

Name origin: From Cucurbitaceae (the gourd family; from Latin cucurbita = gourd). Cucurbitacins are a class of highly oxygenated tetracyclic triterpenoids unique to the Cucurbitaceae — at least 12 major types (A through T) are known, with cucurbitacin B and E being the most pharmacologically studied. The characteristic structural feature is the cucurbitane skeleton with a 9β,10α-lanostane-type ring system with extensive oxidation. The intense bitterness and cytotoxicity of cucurbitacins is proportional to their degree of oxidation — cucurbitacin B (with multiple ketones and a β-hydroxy ketone) is one of the most potent. Traditional use: Citrullus colocynthis (colocynth, bitter apple, Indrayan in Hindi) is documented as a powerful purgative in Ayurvedic, Unani, and traditional African medicine — used for constipation, intestinal parasites, and dropsy. The purgative action is from cucurbitacins’ intense irritant effect on GI mucosa, producing violent catharsis at medicinal doses. This application is managed by Unani practitioners at precisely calibrated “toxic-but-therapeutic” doses. Research trajectory: The pharmaceutical research interest in cucurbitacins shifted from purgative applications to the discovery that cucurbitacins are potent JAK2/STAT3 inhibitors — an oncologically important signalling pathway constitutively active in many cancers. Cucurbitacin B’s STAT3 inhibitory activity at nanomolar concentrations makes it one of the most potent natural STAT3 inhibitors known. Multiple cancer cell lines and animal tumour models confirm antiproliferative activity. Clinical translation is limited by cytotoxicity. Commercial source: Indrayan Oil Soluble Extract (Citrullus colocynthis) from Herbuno delivers cucurbitacins as the primary active fraction.

---

Evidence for Cucurbitacin Applications

JAK2/STAT3 inhibition — anticancer (Moderate): Cucurbitacin B inhibits JAK2 (Janus kinase 2) autophosphorylation and STAT3 phosphorylation (Tyr705) at IC50 values of 0.5–5 μM. STAT3 is constitutively activated in over 70% of human cancers (breast, prostate, colon, leukaemia, glioblastoma), making it a priority oncology target. Cucurbitacin B’s STAT3 inhibitory potency compares favourably with pharmaceutical STAT3 inhibitors in development. Antiproliferative activity confirmed in multiple cancer cell lines and xenograft animal models. Claim strength: Moderate (compelling preclinical; clinical trials limited by toxicity).

Anti-inflammatory: Cucurbitacin E inhibits the actin cytoskeleton-regulating Rho/ROCK pathway and reduces pro-inflammatory cytokine secretion. Anti-inflammatory activity at sub-purgative doses may be relevant for specific anti-inflammatory applications. Claim strength: Moderate.

Traditional purgative (Ayurvedic/Unani — high traditional evidence, narrow margin): Cucurbitacin-rich colocynth preparations are among the most potent botanical purgatives documented — producing rapid, powerful catharsis at 0.1–0.3 g doses of dried fruit. The narrow therapeutic margin (toxic catharsis vs therapeutically calibrated doses) requires expert practitioner guidance. Claim strength: High (traditional; mechanism established).

---

Frequently Asked Questions — Cucurbitacin

Why is colocynth/Indrayan so bitter?
Colocynth is among the bitterest plants known — cucurbitacins are detectable by taste at concentrations of approximately 1 ppb, similar to absinthin in wormwood. This extreme bitterness is a plant defence strategy against herbivores. The evolutionary context: all Cucurbitaceae (cucumber, pumpkin, squash, melon, courgette) are descended from ancestors that produced cucurbitacins for defence. Modern cultivated varieties have had cucurbitacin biosynthesis genetically selected out — making cucumbers and squash non-bitter. Wild or ancestral cucurbit species retain cucurbitacin production.

Are cucumbers or watermelons toxic due to cucurbitacins?
Commercial cucumbers and watermelons have been bred to eliminate cucurbitacin content — they are non-bitter and non-toxic. Occasionally, through back-crossing, mutation, or cross-pollination with wild relatives, cucurbitacin-containing cucumbers or courgettes are produced. These “bitter cucumber” incidents cause nausea, vomiting, diarrhoea, and occasionally more severe toxicity — the “toxic courgette syndrome” reports in the medical literature. A simple taste test (biting the cucumber end — the most bitter area — and tasting before eating) is the recommended safety check when wild-collected or unusual cucurbit varieties are consumed.

Is cucurbitacin B being developed as a pharmaceutical?
Multiple pharmaceutical companies have investigated cucurbitacin B as a STAT3 inhibitor lead for cancer treatment. However, the extreme cytotoxicity at systemic doses (making the therapeutic window very narrow for systemic cancer treatment) has hampered clinical development. Analogue programmes seeking to reduce toxicity while retaining STAT3 inhibition are ongoing. Targeted delivery approaches (nanoparticles, antibody conjugates) may eventually make cucurbitacin B usable in oncology contexts where systemic toxicity can be mitigated by precise tumour-targeted delivery.

Why is colocynth used in Unani medicine if it is so toxic?
Unani medicine (and Ayurveda) has a sophisticated framework for using toxic plants therapeutically via precise dose calibration, detoxification (islah) procedures, and compound formulations that buffer single-ingredient toxicity. Colocynth (Hanzal in Arabic, Indrayan in Hindi) is used in Unani specifically because its dramatic purging action is therapeutically appropriate for conditions of severe constipation or abdominal dropsy where gentler laxatives fail. The Unani dose (typically 0.1–0.3 g of detoxified preparation) is calibrated well below the emetic-toxic threshold while remaining cathartic. This represents sophisticated empirical pharmacology predating formal toxicology by millennia.

Related compounds: Momordicin, Charantin, Absinthin, Saikosaponin A

---

Claim-strength scale – High = multiple human RCTs; Moderate = limited trials or strong preclinical convergence; Emerging = early-stage lab or animal data.

← HerbIQ Compound Index · HerbIQ P02: Extraction · HerbIQ P03: Delivery